The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Fluad Tetra

Seqirus Netherlands B.V.EU/1/20/1433/001-004

Main Information

Trade NameFluad Tetra
Active SubstancesA/(H1N1)-LIKE VIRUS ANTIGEN
B (Victoria Lineage) - Like Virus Antigen
B (Yamagata Lineage)-Like Virus Antigen
Dosage FormSuspension for injection in pre-filled syringe
Licence HolderSeqirus Netherlands B.V.
Licence NumberEU/1/20/1433/001-004

Group Information

ATC CodeJ07BB02 influenza, inactivated, split virus or surface antigen


License statusAuthorised
Licence Issued20/05/2020
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back